BDBM487314 US10947254, Example 5-36::US11780852, Example 5-36

SMILES CCC1(S(=O)(=O)N2[C@@H]3CC[C@H]2C[C@H](Nc2nc(Nc4cc(C)[nH]n4)cc4nc(CN5CCN(C)CC5)ccc24)C3)CC1

InChI Key InChIKey=MTIAHOJMIIQANM-UHFFFAOYSA-N

Data  8 KI

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 487314   

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi: <0.100nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
9/28/2021
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK3(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProtUniProtKB/TrEMBL
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kinase reaction buffer (50 mM HEPES, pH 7.5, 0.01%...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
10/29/2025
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL

TargetTyrosine-protein kinase JAK1(Human)
Theravance Biopharma R&D Ip

US Patent

LigandBDBM487314(US10947254, Example 5-36 | US11780852, Example 5-3...)Copy SMILESCopy InChI

Affinity DataKi:  0.550nMAssay Description:Biochemical JAK and Off-Target Kinase Assays. A panel of four LanthaScreen JAK biochemical assays (JAK1, 2, 3 and Tyk2) were carried in a common kin...More data for this Ligand-Target Pair

Target InfoPDBKEGG
UniProtKB/SwissProt
GoogleScholar

Ligand InfoPC cidPC sidSimilars

In Depth
Date in BDB:
11/17/2023
Entry Details
Copy BDB DOIUS Patent

Copy reaction URL